MAM
MBII

Meeder Asset Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Meeder Asset Management’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,062
Closed -$1K – 2364
2020
Q3 		$1K Sell
1,062
-266
-20% -$323 ﹤0.01% 2092
2020
Q2 		$2K Hold
1,328
– – ﹤0.01% 1834
2020
Q1 		$1K Buy
+1,328
New +$1.41K ﹤0.01% 2273
2018
Q3 		– Sell
-524
Closed -$964 – 1743
2018
Q2 		$964 Buy
+524
New +$975 ﹤0.01% 1498

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Meeder Asset Management's MBII Position: Q4 2020 in Review

Meeder Asset Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2020, closing a stake of 1,062 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in MBII in Q2 2018 and held it in 4 quarters. The position peaked at $2K in Q2 2020. 62 funds tracked by Wall St. Rank hold MBII as of Q4 2020.

  • Meeder Asset Management reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2020 after selling out during the quarter.
  • Meeder Asset Management sold 1,062 Marrone Bio Innovations, Inc. shares in Q4 2020, an estimated $1K.
  • Meeder Asset Management first reported a position in Marrone Bio Innovations, Inc. in Q2 2018 and held it in 4 quarters.
  • Meeder Asset Management's Marrone Bio Innovations, Inc. position peaked at $2K in Q2 2020.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.